Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Harvard Business School
Colorcon
AstraZeneca
McKinsey

Last Updated: August 9, 2022

Drugs in MeSH Category Mineralocorticoid Receptor Antagonists


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth SPIRONOLACTONE spironolactone TABLET;ORAL 040353-003 Mar 15, 2006 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Amneal Pharms SPIRONOLACTONE spironolactone TABLET;ORAL 091426-001 Jul 2, 2010 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Vangard SPIRONOLACTONE spironolactone TABLET;ORAL 087648-001 Feb 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Purepac Pharm SPIRONOLACTONE spironolactone TABLET;ORAL 087998-001 Oct 14, 1983 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Accord Hlthcare SPIRONOLACTONE spironolactone TABLET;ORAL 203512-002 Sep 19, 2016 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Try it Free

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Dow
Harvard Business School
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2022 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2022 - 2023
 NCE-1 Patent Challenge Dates 2022 - 2023
 ClinicalTrialExchange - Connecting volunteers and trials
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group